Get started
Author

Mitsuru Sakakibara

Observed names: M SAKAKIBARA, M. Sakakibara
ORCID: 0000-0003-4649-2082
Observed ORCID: 0000-0003-4649-2082
OpenAlex ID: A5041655188
Reduced Numbers and Impaired Ability of Myeloid and Plasmacytoid Dendritic Cells to Polarize T Helper Cells in Chronic Hepatitis C Virus Infection
2004 · Tatsuya Kanto, Michiyo Inoue, et al. · The Journal of Infectious Diseases · 223
Involvement of the p38 mitogen‐activated protein kinase cascade in hepatocellular carcinoma
2003 · Kenya Iyoda, Yutaka Sasaki, et al. · Cancer · 152
PDF
TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis
2012 · Tokuhiro Matsubara, Tatsuya Kanto, et al. · Hepatology · 144
Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll‐like receptors and retinoic acid inducible gene‐I
2008 · Masanori Miyazaki, Tatsuya Kanto, et al. · Journal of Medical Virology · 61
Subclassification of patients with intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinoma using the up-to-seven criteria and serum tumor markers
2016 · Haruki Kimura, Kazuyoshi Ohkawa, et al. · Hepatology International · 55
Impaired Function of Dendritic Cells Circulating in Patients Infected with Hepatitis C Virus Who Have Persistently Normal Alanine Aminotransferase Levels
2005 · Tatsuya Kanto, Michiyo Inoue, et al. · Intervirology · 54
Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection
2012 · Koyo Higashitani, Tatsuya Kanto, et al. · Journal of Gastroenterology · 48
Clinical Trial of the Intratumoral Administration of Labeled DC Combined With Systemic Chemotherapy for Esophageal Cancer
2012 · Shinichi Fujiwara, Hisashi Wada, et al. · Journal of Immunotherapy · 45
Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide
2011 · Mitsuru Sakakibara, Tatsuya Kanto, et al. · Cancer Immunology Immunotherapy · 43
Prospective Comparison of Gd-EOB-DTPA-Enhanced MRI with Dynamic CT for Detecting Recurrence of HCC after Radiofrequency Ablation
2017 · Yasuharu Imai, Kazuhiro Katayama, et al. · Liver Cancer · 37
Three-Dimensional Registration of Images Obtained Before and After Radiofrequency Ablation of Hepatocellular Carcinoma to Assess Treatment Adequacy
2014 · Mitsuru Sakakibara, Kazuyoshi Ohkawa, et al. · American Journal of Roentgenology · 35
Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis
2009 · I. Itose, T. Kanto, et al. · Journal of Viral Hepatitis · 33
Reduced expression and functional impairment of Toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection
2006 · T YAKUSHIJIN, T KANTO, et al. · Hepatology Research · 31
Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
2023 · Kazuki Maesaka, Ryotaro Sakamori, et al. · PLoS ONE · 29
PDF
Enhanced ability of peripheral invariant natural killer T cells to produce IL-13 in chronic hepatitis C virus infection
2006 · Michiyo Inoue, Tatsuya Kanto, et al. · Journal of Hepatology · 28
Impaired ability of interferon‐alpha‐primed dendritic cells to stimulate Th1‐type CD4 T‐cell response in chronic hepatitis C virus infection
2006 · H. Miyatake, T. Kanto, et al. · Journal of Viral Hepatitis · 26
Pseudotype hepatitis C virus enters immature myeloid dendritic cells through the interaction with lectin
2004 · Aki Kaimori, Tatsuya Kanto, et al. · Virology · 26
PDF
Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: A crucial role of CD25−FOXP3− T cells
2012 · Naruyasu Kakita, Tatsuya Kanto, et al. · International Journal of Cancer · 24
Chemotherapy-Induced Sclerosing Cholangitis Caused by Systemic Chemotherapy
2019 · Akira Kusakabe, Kazuyoshi Ohkawa, et al. · ACG Case Reports Journal · 18
Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study
2024 · Machiko Kai, Hayato Hikita, et al. · PLoS ONE · 17
PDF
Quick Generation of Fully Mature Dendritic Cells From Monocytes With OK432, Low-Dose Prostanoid, and Interferon-?? as Potent Immune Enhancers
2005 · Mitsuru Sakakibara, Tatsuya Kanto, et al. · Journal of Immunotherapy · 16
Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis
2022 · Yuki Tahata, Ryotaro Sakamori, et al. · Hepatology Research · 13
Effect of zinc supplementation in patients with type C liver cirrhosis
2011 · Kazuhiro Katayama, Mitsuru Sakakibara, et al. · Open Journal of Gastroenterology · 13
PDF
Clinical course of hepatitis C virus‐positive patients with decompensated liver cirrhosis in the era of direct‐acting antiviral treatment
2021 · Kazuki Maesaka, Ryotaro Sakamori, et al. · Hepatology Research · 12
Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon‐α and ribavirin therapy for chronic hepatitis C patients
2007 · Ichiyo Itose, Tatsuya Kanto, et al. · Journal of Medical Virology · 12
Works count: 54
Citation count: 1,288
H-index: 18
I10-index: 29
Year
Topic
Type